{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-change-control-management”
},
“headline”: “SOP for Change Control Management”,
“description”: “This SOP establishes procedures for Change Control Management in clinical research, ensuring compliance with FDA, EMA, CDSCO, WHO, and ICH GCP guidelines. It defines processes for initiating, assessing, approving, implementing, and documenting changes in systems, processes, protocols, and vendors.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}
Published on 22/12/2025
Standard Operating Procedure for Change Control Management
| SOP No. | CR/OPS/100/2025 |
| Supersedes | NA |
| Page No. | 1 of 45 |
| Issue Date | 26/08/2025 |
| Effective Date | 01/09/2025 |
| Review Date | 01/09/2026 |
Purpose
The purpose of this SOP is to define the process for effective Change Control Management in clinical research. Changes in systems, processes, vendors, and trial protocols must be
Scope
This SOP applies to sponsors, CROs, investigators, QA, vendors, and clinical site staff involved in clinical trial activities. It covers changes related to trial protocols, SOPs, computerized systems, investigational product handling, data management systems, QMS, and vendor management processes.
Responsibilities
- Sponsor: Defines and oversees change control policies across clinical programs.
- QA: Reviews and approves change control records and ensures regulatory compliance.
- Investigators: Implement and document site-level changes in ISF/TMF.
- CROs: Escalate changes to sponsors and maintain documentation.
- Vendors: Seek approval before implementing changes that impact trial processes.
Accountability
The Sponsor’s Quality Head is accountable for ensuring changes are controlled, risk-assessed, documented, and implemented effectively. QA is accountable for auditing and verifying compliance of the change control process.
Procedure
1. Initiation
1.1 Any proposed change must be documented in the Change Control Request Form (Annexure-1).
1.2 Submit the request to QA for review.
2. Impact and Risk Assessment
2.1 Assess risks associated with the change, including impact on subject safety, data integrity, and regulatory compliance.
2.2 Record the assessment in Change Control Risk Log (Annexure-2).
3. Review and Approval
3.1 QA reviews all proposed changes for compliance with GCP and regulatory guidelines.
3.2 Obtain approval from the Sponsor and relevant stakeholders.
3.3 Document decisions in Change Control Approval Log (Annexure-3).
4. Implementation
4.1 Implement approved changes according to defined timelines.
4.2 Train staff on changes and document training in Training Log.
4.3 Update relevant SOPs, TMF, and ISF records.
5. Verification
5.1 QA verifies that changes were implemented as planned.
5.2 Maintain Change Implementation Verification Log (Annexure-4).
6. Documentation and Archiving
6.1 Archive all change control records in TMF.
6.2 Retain records as per global retention timelines.
Abbreviations
- SOP: Standard Operating Procedure
- QA: Quality Assurance
- CRO: Contract Research Organization
- TMF: Trial Master File
- ISF: Investigator Site File
- QMS: Quality Management System
Documents
- Change Control Request Form (Annexure-1)
- Change Control Risk Log (Annexure-2)
- Change Control Approval Log (Annexure-3)
- Change Implementation Verification Log (Annexure-4)
References
- ICH E6(R2/R3) – Quality Management and Change Control
- FDA – Change Management Guidance
- EMA – Quality System Change Control Standards
- CDSCO – Clinical Research Change Management
- WHO – Change Control in Clinical Trials
Version: 1.0
Approval Section
| Prepared By | Ravi Kumar, QA Specialist |
| Checked By | Sunita Reddy, QA Officer |
| Approved By | Dr. Anil Sharma, Head Clinical Quality |
Annexures
Annexure-1: Change Control Request Form
| Date | Requested By | Description of Change | Reason |
|---|---|---|---|
| 01/09/2025 | Meena Sharma | Update EDC System | Vendor upgrade |
Annexure-2: Change Control Risk Log
| Date | Change ID | Risk Identified | Impact | Mitigation |
|---|---|---|---|---|
| 05/09/2025 | CC-2025-01 | Data migration risk | High | Perform validation |
Annexure-3: Change Control Approval Log
| Date | Change ID | Approved By | Decision | Remarks |
|---|---|---|---|---|
| 10/09/2025 | CC-2025-01 | Sponsor QA | Approved | Proceed with validation |
Annexure-4: Change Implementation Verification Log
| Date | Change ID | Verified By | Result | Status |
|---|---|---|---|---|
| 20/09/2025 | CC-2025-01 | QA Manager | Implementation successful | Closed |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
|---|---|---|---|---|
| 26/08/2025 | 00 | Initial version | New SOP creation | Head Clinical Quality |
For more SOPs visit: Pharma SOP